Welcome to our dedicated page for Skinhealth Systems news (Ticker: SKIN), a resource for investors and traders seeking the latest updates and insights on Skinhealth Systems stock.
SkinHealth Systems Inc. reports developments tied to its global medical aesthetics business, with recurring updates on financial results, margin performance, adjusted EBITDA, installed-base activity and its recurring consumables model. The company, formerly The Beauty Health Company, trades on the Nasdaq Capital Market under the symbol SKIN.
Company news also covers the Hydrafacial platform, SkinStylus microneedling and nano-channeling treatments, HydraScalp with Keravive, provider adoption, consumer skin-health research, board appointments and the completed corporate rebrand to SkinHealth Systems.
The Beauty Health Company (NASDAQ:SKIN) will host its first Investor Day on September 15, 2022, in New York City. The event features presentations from the executive committee, including President and CEO Andrew Stanleick, focusing on the company's strategy, addressable market, business model, and financial performance. The livestream starts at 9:00 a.m. ET and ends at 1:00 p.m. ET, with a live Q&A session included. A recording will be available post-event.
The Beauty Health Company (NASDAQ: SKIN) has appointed Jon Arnold as President, EMEA, and Stefanie Gebauer as President, Southeast Asia, to enhance its commercial leadership. These appointments are part of a strategic plan to capture growth in the global beauty-health market, leveraging the Hydrafacial brand. Arnold and Gebauer will oversee local teams and the rollout of Hydrafacial’s next-generation delivery system, Syndeo, across their regions in 2023. The company aims to increase market penetration and enhance brand awareness, tapping into the growing demand for innovative beauty technologies.
The Beauty Health Company (NASDAQ:SKIN) announced a partnership with Innerskin to introduce Hydrafacial at the Galeries Lafayette in Paris, located within La Wellness Galerie, set to open in September. This new wellness space spans 30,000 sq. ft. and is touted as Europe’s largest dedicated wellness area. The initiative aims to enhance customer experience by integrating beauty and wellness, driving foot traffic to the store, and positioning Hydrafacial treatments as essential within skincare plans.
The Beauty Health Company (NASDAQ: SKIN) reported all-time high quarterly net sales of $103.5 million for Q2 2022, marking a 55.7% increase YoY. Net income reached $7.9 million, contrasting sharply with a net loss of $139.4 million in Q2 2021. The company attributed strong results to the growing demand for its Hydrafacial products, raising its full-year net sales guidance to $340-$350 million. However, it also anticipates ongoing supply chain challenges and inflationary pressures may affect gross margins in the upcoming quarters.
The Beauty Health Company (NASDAQ: SKIN) has announced its inaugural Investor Day set for September 15, 2022, at 9:00 AM ET, in New York. The agenda includes discussions on the company's business model, market potential, financial performance, and future growth strategy, with a live Q&A session following. In-person attendance is by invitation only, and registration is required. A live webcast will also be offered on the company's investor relations website, with a recording available post-event. Beauty Health's HydraFacial brand leads in hydradermabrasion experiences globally.
The Beauty Health Company (NASDAQ:SKIN) will report its second quarter 2022 financial results on August 9, 2022, before market open. Following this, an investor conference call is scheduled for 8:30 a.m. Eastern Time. Investors and analysts can join the call via webcast, with a recording available three hours post-call. HydraFacial, the company's flagship brand, operates in over 90 countries with more than 21,000 delivery systems.
The Beauty Health Company (NASDAQ:SKIN) has expanded its partnership with Murad to launch the new Clarifying Booster for HydraFacial, designed for breakout-prone skin. This booster uses powerful ingredients like Salicylic Acid and Glycolic Acid for exfoliation, combined with Ginger Root Complex and Witch Hazel to soothe and purify the skin. This collaboration enhances the HydraFacial experience, offering a scientifically proven formulation that promotes clearer skin. The new booster complements existing Murad offerings and reinforces the brands' commitment to innovative skincare solutions.
The Beauty Health Company (NASDAQ:SKIN) announced the immediate appointment of Marla Beck, founder of Bluemercury, to its Board of Directors. Beck's extensive experience in leading growth-stage companies and her entrepreneurial accolades, including being an Ernst and Young Entrepreneur of the Year National Finalist, position her as a transformative addition to the board. Executive Chairman Brent Saunders expressed confidence in Beck’s ability to provide fresh perspectives and drive the company's growth as it seeks to enhance consumer self-confidence through its HydraFacial brand.
The Beauty Health Company (NASDAQ: SKIN) announced that its CEO Andrew Stanleick and CFO Liyuan Woo will present at multiple investor conferences this spring. Key events include the Cowen & Company 6th Annual Future of the Consumer Conference on May 24, 2022, the William Blair 42nd Annual Growth Stock Conference on June 9, 2022, and the Jefferies Global Consumer Conference from June 20 to 22, 2022. Replays of these presentations will be available on the company’s investor relations website.
The Beauty Health Company (NASDAQ:SKIN) announces its second annual GLOWvolution tour, starting May 20 in Fort Worth, TX. This mobile spa will visit five cities, offering complimentary HydraFacial treatments. Featuring 11 treatment chairs and additional outdoor setups, the tour aims to engage consumers and enhance brand visibility. The tour also allows participants to share their experiences on social media. With a growing footprint of 21,719 HydraFacial Delivery Systems in over 90 countries, the company is focused on democratizing skincare solutions.